文献速递头颈部肿瘤放疗

治疗1年时的吞咽困难与脑干下部平均剂量相关

Dysphagia at 1 Year is Associated With Mean Dose to the Inferior Section of the Brain Stem.
PubMed 文献 · Int J Radiat Oncol Biol Phys · 2023-06-17

本研究纳入104例接受根治性(放化疗)的口咽癌患者,采用基于体素的图像数据挖掘分析放疗剂量与治疗1年时3种吞咽功能评估指标的关系,发现脑干下部重叠区域的平均剂量与吞咽困难显著相关,所有临床模型加入该区域平均剂量后均显著改善(P≤.006),作者认为需在独立队列中验证。

要点

  • 基于体素的图像数据挖掘显示,与3种吞咽指标相关的剂量区域重叠于脑干下部。
  • 所有临床模型加入重叠区域平均剂量后均显著改善(P≤.006)。
  • 咽缩肌剂量学显著改善水吞咽试验(P=.04),但未显著改善PSS-HN或MDADI(P≥.06)。

核心结论

  • 在这项假设生成研究中,脑干下部平均剂量与治疗后1年吞咽困难强烈相关。
  • 识别区域包含延髓吞咽中枢,可能提供机制解释。
  • 需在独立队列中验证。

研究设计与样本

  • 研究纳入104例接受根治性(放化疗)的口咽癌患者。
  • 采用基于体素的图像数据挖掘技术,将全部患者计划剂量矩阵空间归一化至3个参考解剖。
  • 通过体素统计和置换检验寻找与1年吞咽指标相关的剂量区域。

主要发现

  • 图像数据挖掘显示特定区域剂量与3种吞咽结局均呈高度显著关联,区域重叠于脑干下部。
  • 所有临床模型加入重叠区域平均剂量后均显著改善(P≤.006)。
  • 咽部剂量学显著改善水吞咽试验(P=.04),但未显著改善PSS-HN或MDADI(P≥.06)。

关键数值与推荐

  • 吞咽功能采用MD Anderson吞咽困难量表(MDADI)、饮食正常化功能状态量表(PSS-HN)和水吞咽试验(WST)3种验证指标评估。
  • 临床基线模型通过后向逐步选择法建立。
  • 加入识别区域平均剂量后模型区分度的改善用赤池信息准则量化。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文为假设生成研究。
  • 需在独立队列中验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Dysphagia is a common toxicity after head and neck (HN) radiation therapy that negatively affects quality of life. We explored the relationship between radiation therapy dose to normal HN structures and dysphagia 1 year after treatment using image-based datamining (IBDM), a voxel-based analysis technique. METHODS AND MATERIALS: We used data from 104 patients with oropharyngeal cancer treated with definitive (chemo)radiation therapy. Swallow function was assessed pretreatment and 1 year posttreatment using 3 validated measures: MD Anderson Dysphagia Inventory (MDADI), performance status scale for normalcy of diet (PSS-HN), and water swallowing test (WST). For IBDM, we spatially normalized all patients' planning dose matrices to 3 reference anatomies. Regions where the dose was associated with dysphagia measures at 1 year were found by performing voxel-wise statistics and permutation testing. Clinical factors, treatment variables, and pretreatment measures were used in multivariable analysis to predict each dysphagia measure at 1 year. Clinical baseline models were found using backward stepwise selection. Improvement in model discrimination after adding the mean dose to the identified region was quantified using the Akaike information criterion. We also compared the prediction performance of the identified region with a well-established association: mean doses to the pharyngeal constrictor muscles. RESULTS: IBDM revealed highly significant associations between dose to distinct regions and the 3 outcomes. These regions overlapped around the inferior section of the brain stem. All clinical models were significantly improved by including mean dose to the overlap region (P ≤ .006). Including pharyngeal dosimetry significantly improved WST (P = .04) but not PSS-HN or MDADI (P ≥ .06). CONCLUSIONS: In this hypothesis-generating study, we found that mean dose to the inferior section of the brain stem is strongly associated with dysphagia 1 year posttreatment. The identified region includes the swallowing centers in the medulla oblongata, providing a possible mechanistic explanation. Further work including validation in an independent cohort is required.

来源:Int J Radiat Oncol Biol Phys,查看原文。版权归原作者所有。

引用

  1. Vasquez Osorio E, Abravan A, Green A, et al. Dysphagia at 1 Year is Associated With Mean Dose to the Inferior Section of the Brain Stem. Int J Radiat Oncol Biol Phys. 2023. PMID: 37331569. doi:10.1016/j.ijrobp.2023.06.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。